Article
Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer.
Gastroenterology - 1 Sept 2005
Samowitz Wade S, Albertsen Hans, Herrick Jennifer, Levin Theodore R, Sweeney Carol, Murtaugh Maureen A, Wolff Roger K, Slattery Martha L
Abstract excerpt
BACKGROUND & AIMS: The concept of a CpG island methylator phenotype (CIMP), especially in microsatellite stable colon cancer, is not accepted universally. We therefore evaluated a large population-based sample of individuals with colon cancer and used univariate and multivariate analyses of CIMP with clinicopathologic variables and tumor mutations to determine the biologic relevance of this phenotype. METHODS: A...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
